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ABSTRAK (BAHASA MELAYU) 
 
 
 
 
 
 
Latarbelakang 
 
Tuberculosis merupakan penyakit berjangkit yang kronik yang menjangkiti satu 
pertiga penduduk dunia. Tuberculosis bukan sahaja memberi kesan terhadap fizikal kepada 
pesakit tetapi juga kepada kualiti hidup pesakit berkenaan. Pelbagai factor yang boleh 
mengurangkan kualiti hidup pengidap tuberculosis. Objektif kajian ini adalah untuk 
menentukan kualiti hidup berkaitan kesihatan pengidap tuberculosis pada awal rawatan dan 
pada pengakhiran rawatan intensif serta faktor-faktor yang mempengaruhi kualiti hidup 
pada permulaan rawatan. 
 
 
 
 
Metodologi 
 
Satu kajian‘cross-sectional’ propektif dibuat pada September 2014 sehingga March 
2015melibatkan 60 responden, 35 daripadanya adalah pesakit tuberculosis pulmonary, 18 
pesakit merupakan pesakit tuberculosis extrapulmonary and selebihn yang mengidap kedua-
duanya. Pesakit yang layak akan diberi soalansoalselidik SF36v2 yang dijawab sendiri pada 
permulaan dan pengakhiran fasa intensif. Markah kualiti hidup dibahagikan kepada lapan 
domain. Kesihatan dan komponen terkumpul fizikal dan mental. Perbezaan antara markah 
permulaan dan pengakhiran rawatan intensif diukur mengunakan ‘paired t test’ dan ‘multi 
linear regression’untuk faktor yang mempengaruhi markah kualiti hidup. 
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Keputusan 
 
Markah kualiti hidup meningkat untuk kesemua lapan domain dan komponen keseluruhan 
fizikaldan mental pada pengakhiran fasaintensif. Markah purata PCS pada permulaan rawatan 
adalah 39.2 (SD+10.19) p <0.005, pada pengakhiran fasa intensif 49.1(SD+9.03) dan purata 
perbezaan -9.89.Manakala, markah purata bagi MCS pada permulaan rawatan, pengaakiran 
fasa intensif dan purata perbezaan adalah 42.00(SD+10.77), 50.24(SD+8.79) dan 8.20. 
Bilangan symptom dan pesakit HIV merupakan prediktif yang membezakan markah untuk 
PCS pada permulaan rawatan. Manakala menjadi pesakit HIV merupakan faktor yang 
memberi kesan negatif kepada markah MCS pada permulaan rawatan tuberkulosis. 
 
 
 
 
Kesimpulan 
 
Hasil kajian ini telah membuktikan kualiti hidup berkaitan kesihatan meningkat selepas 
rawatan intensif serta bilangan symptom pada masa diagnose serta pesakit HIV adalah faktor 
            yang mengurangkan markah PCS.Manakala markah MCS lebih rendah untuk pesakit HIV 
            berbanding pesakit lain. 
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ABSTRACT (ENGLISH) 
 
 
 
 
 
 
Background 
 
Tuberculosis is a chronic infectious disease that has infected one third of the world 
population. Tuberculosis not only gives an impact physically but also affects the quality of 
life. The quality of life in tuberculosis patients diminish by multiple factors. The objective of 
this study is to determine the health related quality of life in active tuberculosis patients at the 
beginning and at the end of the intensive treatment and the associated factors of quality of life 
at the beginning of the treatment. 
 
 
Methodology 
 
This is a cross-sectional prospective study done between September 2014 until March 2015 
involving 60 tuberculosis patients in which 35 of them were infected with pulmonary 
tuberculosis, 18 patients were infected with extrapulmonary tuberculosis and 7 patients had 
both pulmonary and extrapulmonary Tuberculosis. All eligible patients were asked to 
complete a self-administered SF36v2 questionnaire at the diagnosis and at the end of the 
intensive phase treatment of tuberculosis. The quality of life score were scored into eight 
health domains, physical and mental component summary. The difference of the quality of 
life score at the beginning and at the end of the intensive phase was assessed using paired      
t-test and multiple linear regression to assess the associated factors for the quality of life 
score. 
 
 
 
 
 
xiv 
 Result 
 
The quality of life score significantly improved all eight domains as well as the physical and 
mental component summary at the end of the intensive phase. For the PCS, the mean score at 
the beginning of treatment was 39.2(SD+10.19), at the end of intensive phase was 49.1 
(SD+9.03) and the mean difference was -9.89. While for the mean MCS scores at the start of 
the treatment, after the intensive phase and the mean difference were 42.00(SD+10.77), 
50.24(SD+8.79) and 8.20, respectively. The number of symptoms at the diagnosis and being 
HIV infected patients were the predictive difference in PCS score at the beginning of the 
treatment of anti-tuberculosis. Being HIV infected patients were the factors that negatively 
affect the MCS score at the beginning of treatment. 
 
 
Conclusion 
 
This study showed that the HQOL improved with intensive phase of treatment. The number of 
symptoms at the diagnosis and being HIV patients were the associated factors that lower the 
physical component summary score(PCS). Similarly, the mental component summary 
score(MCS) was lower in HIV patients than non HIV patients. 
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Introduction: Tuberculosis is a chronic infectious disease that has infected one third of 
the world population. Tuberculosis not only gives an impact physically but also affects the 
quality of life. The quality of life in tuberculosis patients diminish by multiple factors. 
 
 
Objectives: The aims of this study is to determine the health related quality of life in 
active tuberculosis patients at the beginning and at the end of the intensive treatment and the 
associated factors of quality of life at the beginning of the treatment. 
 
 
Methodology: This is a cross-sectional prospective study done between September 2014 
until March 2015 involving 60 tuberculosis patients in which 35 of them were infected with 
pulmonary tuberculosis, 18 patients were infected with extra pulmonary tuberculosis and 7 
patients had both pulmonary and extra pulmonary Tuberculosis. All eligible patients were asked 
to complete a self-administered SF36v2 questionnaire at the diagnosis and at the end of the 
intensive phase treatment of tuberculosis. The quality of life score were scored into eight health 
domains, physical and mental component summary. The difference of the quality of life score at 
the beginning and at the end of the intensive phase was assessed using paired t-test and multiple 
linear regression to assess the associated factors for the quality of life score. 
 
 
Result: The quality of life score significantly improved all eight domains as well as the 
physical and mental component summary at the end of the intensive phase. For the PCS, the 
mean score at the beginning of treatment was 39.2 (SD+10.19), at the end of intensive phase was 
49.1 (SD+9.03) and the mean difference was -9.89. While for the mean MCS scores at the start 
of the treatment, after the intensive phase 
 
and the mean difference were 42.00 (SD+10.77), 50.24(SD+8.79) and 8.20, respectively. The 
number of symptoms at the diagnosis and being HIV infected patients were the predictive 
difference in PCS score at the beginning of the treatment of anti-tuberculosis. Being HIV 
infected patients were the factors that negatively affect the MCS score at the beginning of 
treatment. 
 
 
Conclusion :This study showed that the HQOL improved with intensive phase of 
treatment. The number of symptoms at the diagnosis and being HIV patients were the associated 
factors that lower the physical component summary score (PCS). Similarly, the mental 
component summary score (MCS) was lower in HIV patients than non HIV patients. 
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CHAPTER ONE 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1 Introduction of Tuberculosis 
 
 
Tuberculosis is an infectious disease caused by the Mycobacterium tuberculosis                
(M. tuberculosisbacteria). Tuberculosis typically attacks the lungs 90% of the overall 
cases, as well as affecting other parts of the body, such as lymph nodes, bones, brain and 
others. It is spread through the air when people who have an active TB infection cough, 
sneeze, or otherwise transmit their saliva through the air. 
 
The classical symptom of pulmonary tuberculosis fever, cough with or without hemoptysis 
and loss of weight. The cough usually lasted more than 2 weeks(Miller et al., 2000). 
Patients with extra pulmonary tuberculosis usually presented depend on the organ 
involvement. For example, patient with lymphadenitis tuberculosis usually presented with 
lumps at neck and patient with TB meningitis may come with headache and constuitional 
symptoms then may progress to coma. 
 
The diagnosis confirmed by isolating Myobacterium tuberculoisis from the clinical sample 
namely from the body fluid, sputum or tissue such as lymph nodes and bones. Few 
imaging modalities also may help to assist the diagnosis. 
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Treatment for tuberculosis is difficult and requires the administration of multiple 
antibiotics over a long period of time. Pulmonary tuberculosis treatment period for non 
HIV patient is 6 months which consist of 2 months of intensive phase and another 4 
months for maintenance phase (Malaysia, 2002). 
 
Tuberculosis is a chronic infectious disease which causes devastating symptoms and 
requires long course of treatment, that certainly will cause negative impacts to the 
patient either physically as well as social and mental wellbeing. 
 
 
 
 
 
1.2History of tuberculosis 
 
Throughout history, tuberculosis was called by various names and terms, including 
consumption, phthisis, scrofula, Pott's disease, and the White Plague. During the 18
th
 and 
19
th
 centuries, tuberculosis already reached its epidemic proportion in Europe and North 
America and earned the sobriquet, “Captain Among these Men of Death”(Daniel, 2006). 
Mycobacterium tuberculosis, or Koch's bacillus was revealed as organism for tuberculosis 
in 1882 by Robert Koch, a Prussian physician. Heutilized a new staining method to sputum 
of tuberculosis and found the pathogen. He also developed tuberculin, a purified protein 
derivative of the bacteria, which proved to be an ineffective means of immunization. In 
1908, Charles Mantoux found it was an effective intradermic test for diagnosing 
tuberculosis. 
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The treatment for tuberculosis initially began with surgical intervention including the 
pneumothorax or plombage technique—collapsing an infected lung to "rest" it and 
 
allow the lesions to heal. The first antibiotic against M. tuberculosiswasdiscovered by 
Albert Schatz, Elizabeth Bugie, and Selman Waksmanin in 1944, then isoniazid in 1952 
followed by rifampicin in 1970s. 
 
 
 
 
1.3 Epidemiology of Tuberculosis 
 
 
 
 
1.3.1 Epidemiology of Tuberculosis Worldwide 
 
Tuberculosis infected about one third of the world population (estimated about 2 billion 
people). According to the World Health Organization (WHO), in 2013,estimated 9 million 
individuals developed TB and 1.5 million died(Organization, 2013).This increment was 
also compounded by the HIV pandemic, complacency, neglect towards the disease and 
international movement(CPG, 2012).In 2013, there were estimated 360,000 deaths among 
people who were HIV-positive(Organization, 2013). 
 
 
1.3.2 Epidemiology of Tuberculosis in Asia 
 
Half of tuberculosis cases came from most populous countries of Asia which are 
Bangladesh, China, India, Indonesia, and Pakistan(Dye, 2006).One-third of the world’s 
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burden of tuberculosis (TB), or about 4.9 million prevalent cases, is found in the World 
Health Organization (WHO) South-East Asia Region(Nair et al., 2010). 
 
 
 
 
 
1.3.3 Epidemiology of Tuberculosis in Malaysia 
 
In Malaysia, the number of tuberculosis patients increase throughout the year according to 
CDC Department 2011. The number of new TB cases in the country has increased from 
15,000 in 2005 to 22,710 cases in 2012. While PTB was the most common form of TB in 
Malaysia, extrapulmonary TB (EPTB) still posed a threat. In 2011, the number of cases for 
PTB was 16363 (85%) while for extrapulmonary was 2888 (15%)(CPG, 2012). 
 
 
 
 
 
1.3.4 Epidemiology of Tuberculosis in Terengganu 
 
According to CDC Department the number of cases increased from 661 (2007) to 733 
cases (2012). While the number of death also increased throughout the years with 114 
cases in 2012. 
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1.4 Definition and Classification of Tuberculosis 
 
Tuberculosis is an infectious disease caused by the Mycobacterium tuberculosis (M. 
tuberculosis) bacteria. Tuberculosis commonly involves the lung and it is called 
Pulmonary Tuberculosis (PTB). Tuberculosis may also affect other organs such as lymph 
nodes, bones, spine, eyes, brain and many more other organs known as extrapulmonary 
tuberculosis (EPTB). 
 
 
 
1.5 Etiology of Tuberculosis 
 
Tuberculosis is caused by Mycobacterium tuberculosis, a small, aerobic nonmotile 
bacillus. It has unique clinical characteristics in which it is a high lipid content 
pathogen.This pathogen was first identified and described by Robert Koch in 1882 and he 
received a Nobel Prize in 1905 for this discovery. 
 
 
1.6 Risk Factors for Tuberculosis 
 
 
There are a few important groups of people who have a high risk to get infected. People 
who live with the infected people namely in close contact, which is the household contacts 
have higher risk than people with nonhousehold contact(Moran-Mendoza et al., 2010). The 
immunocompromised people are also included in the high risk group, such as Diabetes 
mellitus (Jeon and Murray, 2008), Human Immunodeficiency Virus infection (Lienhardt et 
al., 2005), Chronic obstructive pulmonary disease, End-stage renal disease, malignancy, 
malnutrition and use of immunosuppresant drugs in rheumatoid arthritis i.e. TNF blockers. 
Substance abusers and cigarette smokers are also included in the high risk group to be 
infected by tuberculosis.(Moran-Mendoza et al., 2010); (Lienhardt et al., 2005) 
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 1.7 Pathogenesis of tuberculosis 
 
a.  Transmission of tuberculosis 
 
 
TB is transmitted via aerosol droplets of 0.5 to 5.0 micrometers in diameter whenever 
infected people cough, sneeze, speak, sing or spit. When the pathogen reaches the 
pulmonary alveoli, it will invade and relipcate within endosomes of alveolar 
macrophages. Phagocytosis occurred to eliminate the pathogen (Kumar et al.,2007). 
 
 
 
 
b. The immune response 
 
 
M tuberculosis has a thick, wavy mycolic acid capsule that protects it from the toxic 
substance. The bacilli will destroy the macrophages by activating the T lymphocytes 
and their lymphokines, whereby the activation is the essence of cell-mediated 
immunity. This immunity also has a detrimental component, called delayed-type 
hypersensitivity. This component causes caseous necrosis of host tissues(Dannenberg, 
1989). Nitric oxide (NO) plays an important role in killingMycobacterium tuberculosis 
by mononuclear phagocytes, in which found in the urine odel of tuberculosis. Genetic 
disruption for inducible NO synthase in mouse, is associated with a significant higher 
risk of disseminationand mortality for tuberculosis infection(Chan et al., 2001). 
Cytokines such as tumor necrosis factor- α and interleukin 1- β , mycobacterial cell 
wall components such as lipoarabinomannan and 19 kD lipoprotein, along with the T-
cell–derived interferon-γ ,also induce NO expression(Chan et al., 2001). 
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c.  The pathology caused by tuberculosis to the body 
 
The primary site of infection in the lung is known as “Ghon focus", usually located 
either in the upper part of the lower lobe, or the lower part of the upper lobe(Kumar et 
al.,2007).Tuberculosis of the lung may also spread from the blood stream or 
hematogenous transmission whereby it is transmitted from distant sites such as 
peripheral lymph nodes, the kidneys, the brain, and the bones(Kumar et al., 2007). It is 
typically located at the upper part of the lung known as Simon focus. 
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1.8 Diagnosis 
 
 
Active tuberculosis is diagnosed by clinical presentation as mentioned in the introduction 
of tuberculosis (sub topic 1.1), supported by imaging and laboratory tests. The diagnosis 
however is confirmed by isolating Mycobacterium tuberculosis from the clinical 
samples.(CPG, 2012). 
 
 
1.8.1 Diagnosis of Pulmonary Tuberculosis (PTB) 
 
 
 
 
a. Imaging 
 
Chest radiograph remainsthe primary modality in PTB. It has higher sensitivity and 
specificity for TB when read by trained readers and detection improved by 1.23 fold 
(Abubakar et al., 2010). Consolidation with cavitation is the hallmark of adult-type 
PTB. 
Computerised tomography (CT) is useful in cases with high clinical suspicion of TB 
with normal CXR. It is able to demonstrate endobronchial lesion, lymphadenopathy 
and pleural complication. High resolution CT has high sensitivity, specificity and 
positive predictive value of 84%, 97% and 98% respectively(Yeh et al., 2010). 
Magnetic Resonance Imaging (MRI) may be considered in pregnant women or 
children. MRI has better soft tissue characteristics especially for pleural and lymph 
node assessment; however it is limited by the cost and accessibility. 
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b. Laboratory 
 
All patients suspected to have PTB should send their sputum specimens for 
microscopic examination in a quality-assured laboratory for at least two sputum.(CPG, 
2012). At least one early morning specimen should be obtained, as this time has the 
highest yield for sputum collection. Microscopic examination of sputum using 
conventional light microscopy in diagnosing PTB however has low sensitivity (20-
60%)(Steingart et al., 2006). 
 
 
 
The newer method, light emitting diode-based fluorescence microscopy (LED FM) has 
benefit over the conventional FM. It is cheaper, has lower maintenance requirement 
and do not need a dark room. The sensitivity and specificity for LED FM on 
pulmonary specimens were 78.3% and 92% respectively(Shenai et al., 2011). 
 
The newer tool for rapid diagnosis of TB is the Nucleic Acid Amplification Tests 
(NAAT). NAAT provide rapid results within 24-28 hours and also can detect the 
presence of Mycobacterium weeks earlier than culture(Control and Prevention, 2009). 
This test has positive predictive values (PPV) of more than 95% with AFB smear 
positive specimens and able to confirm the presence of Mycobacterium in AFB 
negative, culture positive 50-80%(Menzies et al., 2009). 
 
 
Another new test rapid in diagnosing tuberculosis and also detection of rifampicin 
resistance is Xpert MTB/RIF assay. From a meta-analysis study, this test has 
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sensitivity and specificity of 90.4% and 98.4% respectively in PTB. While for the 
rifampicin resistance, the sensitivity was 94% and specificity was 97%. The accuracy 
of Xpert MTB/RIF assay is higher in smear-positive and sensitive of diagnosing PTB 
in adults. The assay has pooled sensitivity of 80% and specificity of 86% in diagnosing 
EPTB(Chang et al., 2012). 
Line probe assay is useful in detecting rifampicin ad isoniazid resistance. The pooled 
sensitivity and specificity for LPA rifampicin resistance demonstrates an excellent 
accuracy of 98.1% and 98.7% respectively. Whilst for isoniazid resistance, the pooled 
sensitivity and specificity was 88.7% and 99.2% (Ling et al., 2008) 
 
 
 
1.8.2 Diagnosis of Extrapulmonary Tuberculosis (EPTB) 
 
a. Imaging 
 
Ultrasound is useful to demonstrate effusion and to guide for diagnostic tapping for 
pleural TB. CT and MRI imaging have great values to diagnose musculoskeletal TB. 
The tools are useful in demonstrating a small focus of bone infection as well as the 
extent of the disease. MRI is preferred in diagnosing tuberculous spondylitis. (Engin et 
al., 2000). 
 
 
In diagnosing TB involving the central nervous system, CT and MRI are very useful. 
CT is able to demonstrate hydrocephalus as complication of TB involves brain 
parenchyma and also enhancement of the basal cisterns, whilst MRIbetter demonstrates 
the involvement of the spinalcord and cranial nerves(Engin et al., 2000).The imaging 
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modalities for abdominal TB are US, CT and barium studies with diagnostic yields 
83% for barium meal follow through, 80% for CT and 77% for US (Khan et al., 2006). 
 
 
 
b. Laboratory 
 
EPTB have a lower bacterial load problem in sample collection compared to PTB. In 
order to support or confirm the diagnosis, samples for Mycobacterium tuberculosis 
culture need to be obtained from the affected sites such as cerebrospinal fluid (CSF), 
pleural fluid, fine needle aspiration (FNA) and/or biopsy from lymph node, pleura, 
intestines, skin and any other infected sites. The presence of caseating granulomas, or 
granulomas with Langerhan’s giant cells on histologyor cytology of the specimen is 
highly suggestive of tuberculosis but they are not specific(CPG, 2012). 
In a meta-analysis by Liang QL et al., the measurement of Adenosine Deaminase 
(ADA) level in pleural effusion is useful for the diagnosistuberculous pleurisy with 
high sensitivity and specificity for diagnosis. In clinical suspected tuberculous 
lymphadenitis, combining cytology with microbiology(smear and culture) increases 
diagnostic yield from 67% to 91% (Asimacopoulos et al., 2010). 
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1.9 Management 
 
 
 
 
A  standardized  and  appropriate  treatment  regime  is  most  crucial  in  TB  control. 
 
Appropriate transmission and prevent emergence of MDRTB. 
 
 
Based on well-designed randomized controlled trial (RCT) for many years, treatment 
regime for newly diagnosed PTB patient is six-month regimen consisting of two months of 
daily EHRZ* (2EHRZ) followed by four months of daily HR* (4HR) (Fox et al., 1999). 
 
In a systemic review done in 2009 by Menzies D et al. showed significant worse outcome 
with shorter rifampicin treatment regime(Menzies et al., 2009). Rifampicin should be used 
for the whole treatment regime including maintenance. The optimal duration of treatment 
for PTB smear positive is at least six months(CPG, 2012).There is lack of evidence for 
treatment duration for EPTB, therefore it has been conflicting recommendation. The 
recommendation by WHO are, all EPTB should contain 6 months of rifampicin based 
regime of treatment except TB meningitis is 9 -12 months whereas bone and joint TB is 9 
months. (Organization, 2010). 
 
 
 
In 1995, WHO launched the Direct Observed Therapy, Short course (DOTS), whereby this 
strategy combines drug treatment with political commitment to ensure adherence. DOT 
increased completion rate compared to self-administered therapy as showed by a study 
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done by Anuwatnonthakate A et al(OR=3.3, 95% CI 2.4 to 4.5)(Anuwatnonthakate et al., 
2008). 
 
The practice of DOT Malaysia was reported to be 93-100% according to Sistem Maklumat 
Tibi Kementerian Kesihatan Malaysia. 
 
 
A part from treating a person with active infection with antibiotics, the aim of TB 
management is to control TB infection. The preventivemeasures include screening of TB 
contact, screening TB for high risk group andpreventive measures for health care workers. 
Regarding TB contact, Index TB patients include both smear positive and negative 
cases.Contact has higher risk to acquire all type of TB than non contact(Morrison et al., 
2008). 
 
 
With regards to the preventive measures to control tuberculosis and isolation of 
tuberculosis patients, the aim of isolation of tuberculosis patient is to control nosocromial 
tuberculosis infection transmissions beyond the resources of low-income countries(Harries 
et al., 1997). 
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1.10 Introduction to health related quality of life 
 
 
WHO defined health as a state of complete physical, mental and social well-being and not 
merely the absence of disease or infirmity (WHO, 1948). Apart from the physical 
symptoms, the patient also faces several mental and social problems that have a great 
impact on the wellbeing and quality of life of the patient. Health-related quality of life 
(HRQOL) is a multi-dimensional concept that includes domains related to the physical, 
mental, emotional and social functioning (Khanna and Tsevat, 2007). HRQOL assessment 
is a relatively new index for health measurement. It is what patients perceived about their 
health. The conventional clinical and investigation assessment was unable to quantify the 
impairment of quality of life in a patient. Therefore a framed question of HRQL score need 
to be done to assess the patient’s perception of improvement (Dhingra and Rajpal, 2005). 
 
Patients living with a chronic disease such as tuberculosis, the impact is often 
encompassing, affecting patients life physically as well as their social, economic and 
physiological wellbeing (Rajeswari et al., 2005). 
 
 
 
A systemic review study measuring health related quality of life in tuberculosis which was 
done in Canada by Na Guo, Fawziah Marra and Carlo A Marra (2009) revealed that there 
was no established specific instrument to measure quality of life in tuberculosis patients. 
Despite the overall study which showed improvement of quality of life with the treatment, 
the score was still low in tuberculosis patients even after the completion of treatment as 
compared to the general population (Guo et al., 2009). 
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A study conducted in Yemen 2009 showed that the HRQOL score of pulmonary and extra 
pulmonary tuberculosis patients improved significantly at the end of first month of follow 
up and at the end of the intensive phase (Othman et al., 2011). 
 
 
 
 
 
A study using DR-12 scale done in New Delhi showed a significant difference between 
scores in the pulmonary and extrapulmonary cases in both symptoms and total HRQOL 
scores. In terms of sputum smear, sputum negative showed a higher symptom score. 
HRQOL scores also showed a negative correlation with sputum grading at 0 week, 4 
weeks and 8 weeks for all three scores, symptom, socio-physiological and exercise 
adaptation and total score (Dhingra and Rajpal, 2005). 
 
 
 
 
 
The other study which compared tuberculosis patients with the normal population showed 
that tuberculosis patients had significantly lower mean scores for overall quality of life 
score. The physical domain was the worst effected domain followed by the psychological 
domain (Dhuria et al., 2008). 
 
 
 
 
 
Tuberculosis also causes social implications such as stigma which was revealed by a few 
studies. It continues even after completed treatment and bacteriologically cured (Chamla, 
2004; Rajeswari et al., 2005; Dhuria et al., 2008). 
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HRQOL assessment in TB research is relatively new. In a systemic review regarding 
measurement tools for HRQOL in tuberculosis patients, the most frequently used HRQOL 
instrument is SF-36 currently. 6 out of 12 studies reviewed to have used SF-36 as HRQOL 
assessment tool. SF-36 appeared to be a valid and reliable tool to be used in TB (Guo et 
al., 2009). 
 
A study conducted in USA by using a focus group to assess HRQOL of tuberculosis 
patients revealed that more specific aspects of life were affected such as isolation, as 
patients diagnosed with tuberculosis were admitted to the isolation ward and social 
support, unanticipated effects on sexual functioning and financial wellbeing (Hansel et al., 
2004). 
 
 
 
 
 
Sararaks et al (2005) reported that the psychometric properties of SF36 Malay version was 
acceptable. The internal consistency revealed Cronbach’s αs of more than 0.07 for all 
items except for SF. This study was based based on multi centre study on the asthmatic and 
population based study(Sararaks et al., 2005). 
 
 
 
 
 
The factor that influence the quality of life in tuberculosis patients are socioeconomic 
status including exposure to second hand smoker and low perceived social support, in 
addition to clinical factors. (Masumoto et al., 2013). While other study done in Pakistan 
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showed that women enjoyed better quality of life compared to men and rural patients have 
better HRQOL score compared to the urban patients. Other factors that affect the HRQOL 
are disease severity, use of drugs and death threats. (Masood et al., 2012). A study done in 
Wuhan, China in 2003 found a significant association between the SF36 and age, WBC 
count and number of symptoms, whereas sex and Haemoglobin were the associated factors 
after treatment (Chamla, 2004). 
 
 
 
 
1.10 STUDY BACKGROUND AND RATIONALE 
 
 
Tuberculosis is a chronic debilitating disease. It remains the leading cause of morbidity 
and mortality worldwide especially in resource limited settings. In Malaysia as well as in 
Terengganu, it is as challenging and consuming as ever before. However, there are only 
one study done in Penang which examined the impact of health-related quality of life 
(HRQOL) among tuberculosis patients, especially in relations to factors influencing it (Atif 
et al., 2014). 
 
 
 
 
 
The purpose of this study is to determine the health-related quality of life in active 
tuberculosis patientsin Hospital Sultanah Nur Zahirah, Kuala Terengganu as well as factors 
that influence their quality of life. This study is an extension of Penang study in which only 
included newly diagnosed smear positive patients. This is the only HRQOL study in 
Malaysia included all active tuberculosis patients. 
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When treating physical impairment in tuberculosis patients, the impact of the disease on 
the patient’s quality of life is often not being considered. Recently, there are emerging 
interests in health related quality of life especially the impact of chronic diseasesincluding 
tuberculosis. In this area, the consideration was on what patients perceive regarding their 
disease and their health. Furthermore this is important for patients adherence and curative 
(Marra et al., 2004). Moreover further insight into the factors whichare associated with 
lower quality of life among patients with active TB would enable further steps to be taken 
to improve the patient’s quality of life in the future, thus improving the overall outcome. 
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CHAPTER TWO 
 
 
 
 
OBJECTIVE 
 
 
 
 
2.1 GENERAL OBJECTIVE 
 
To assess the health related quality of life of active tuberculosispatients in Kuala 
Terengganu at the beginning and at the end of the intensive treatments and factors 
influencing their quality of life. 
 
2.2 SPECIFIC OBJECTIVE 
 
i. To comparethe quality of life score of active tuberculosis patientsat the 
beginning of treatment and at the end of the intensive phase. 
ii. To determine the associated factors of quality of life score in active tuberculosis 
patients at the beginning of treatment. 
2.3 RESEARCH QUESTIONS 
 
i. Are there any differencein score of health related quality of life in active 
tuberculosis patients at the beginning of treatment and at the end of the 
intensive phase? 
ii. What are the associated factors that influence health related quality of life 
among active tuberculosis patients in Kuala Terengganu? 
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2.4 RESEARCH HYPOTHESIS 
 
i. The score of health related quality of life score in active pulmonary tuberculosis 
patientswere lower at the beginning of treatment as compared with the end of 
the intensive phase. 
ii. The associated factors that influenced the score of health related quality of life 
are gender, age, region and number of symptoms. 
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CHAPTER THREE 
 
 
 
 
METHODOLOGY 
 
3.1 STUDY DESIGN 
 
For Objective 1 the study design is Prospective cohort and for objective 2 is cross sectional 
study 
 
3.2 STUDY DURATION 
 
September 2014 until March 2015 
 
 
3.3 REFERENCE POPULATION 
 
All active tuberculosis patients in Kuala Terengganu 
 
 
 
 
3.2 SOURCE POPULATION 
 
Tuberculosis patients who were registered under Chest Clinic Hospital Sultanah Nur 
Zahirah, Kuala Terengganu during the study period 
 
 
 
3.5 STUDY AREA 
 
Chest Clinic Hospital Sultanah Nur Zahirah, Kuala Terengganu 
 
 
 
 
 
 
3.6 SAMPLING FRAME 
 
New tuberculosis registration at Chest Clinic Hospital Sultanah Nur Zahirah, Kuala 
Terengganu. 
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3.7 STUDY POPULATION 
 
 
All new active tuberculosis patients who were registered under Chest Clinic Hospital 
Sultanah Nur Zahirah, Kuala Terengganu. 
 
 
 
 
3.7.1 INCLUSION CRITERIA 
 
All active tuberculosis patients who were registered and has completed the intensive phase 
under chest Clinic Hospital Sultanah Nur Zahirah, Kuala Terengganu 
 
 
 
 
3.7.2 EXCLUSION CRITERIA 
 
 
Illiterate patients 
 
 
 
 
 
 
3.8.1 SAMPLING METHOD 
 
Universal sampling 
 
 
All eligible sampling frame within the study period who fulfill the inclusion and exclusion 
criteria were included in the study in view of limited study subject. 
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3.9 MEASURING TOOLS 
 
 
Malay version SF-36 questionnaire. The questionnaire also included the demographic and 
socioeconomic characteristics of patients. The permission for the use of translated Malay 
version of SF-36v2® was obtained from the Quality Metric Inc. The questionnaire 
consist of eight health domains and total of 36 items. Table 3.1 shows the domain and 
items of SF36. The scoring scale for this questionnaire was using Quality Metric’s QM 
Certified Scoring software. 
 
Domain No of Item 
  
Physical Functioning (PF) 10 
Role-Physical (RP) 4 
Bodily Pain (BP) 2 
General Health (GH) 5 
Vitality (VT) 4 
Social Functioning (SF) 2 
Role Emotional (RE) 3 
Mental Health (MH) 5 
Reported Health Transition 1 
Total 36 
 
Sararaks et al (2005) reported that the psychometric properties of SF36 Malay version was 
acceptable. The internal consistency revealed Cronbach’s αs of more than 0.07 for all 
items except for SF. This study was based based on multi centre study on the asthmatic and 
population based study(Sararaks et al., 2005) 
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Table3.1 : The domain and items for SF36v2. 
 
 
 
 
 
 
3.10DATA COLLECTION 
 
Active tuberculosis patients were identified from chest clinic’s registration book during 
the study period. All eligible subject that fulfill inclusion and exclusion criteria informed 
consent were obtained and they were given Malay version SF36v2 questionnaire at the 
baseline and after completed intensive phase. At the baseline they were also given 
socioeconomic, demographic and clinical data form. The study subjects took about 10-15 
minutes to complete the questionnaire. Attempts were made to trace patient at the primary 
care when the enrolled patients did not visit clinic after completed intensive phase. 
Enrolled patient who were unable to participate in this study at the end of intensive phase 
(eg; defaulter, transferred out) were not asked to complete questionnaire. 
 
 
 
3.11ETHICAL APPROVAL 
 
This study granted an ethical approval for implementation by Jawatankuasa Etika 
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code USM/JEPeM/1405170. The ethical clearance is valid from January 2015 until 
December 2015. The approval letter is attached in the Supplementary (sub topic 10.2).This 
study also registered under National Medical Research Registry (NMRR-12-1448-14180). 
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